Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.

INTRODUCTION:Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine...

Full description

Bibliographic Details
Main Authors: Richard D Bell, Christopher Rudmann, Ronald W Wood, Edward M Schwarz, Homaira Rahimi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5761871?pdf=render
_version_ 1818466462507991040
author Richard D Bell
Christopher Rudmann
Ronald W Wood
Edward M Schwarz
Homaira Rahimi
author_facet Richard D Bell
Christopher Rudmann
Ronald W Wood
Edward M Schwarz
Homaira Rahimi
author_sort Richard D Bell
collection DOAJ
description INTRODUCTION:Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine models recapitulating RA-ILD are lacking, and CT outcomes for inflammatory lung disease have yet to be formally validated. To address this, we validate μCT outcomes for ILD in the tumor necrosis factor transgenic (TNF-Tg) mouse model of RA. METHODS:Cross sectional μCT was performed on cohorts of male TNF-Tg mice and their WT littermates at 3, 4, 5.5 and 12 months of age (n = 4-6). Lung μCT outcomes measures were determined by segmentation of the μCT datasets to generate Aerated and Tissue volumes. After each scan, lungs were obtained for histopathology and 3 sections stained with hematoxylin and eosin. Automated histomorphometry was performed to quantify the tissue area (nuclei, cytoplasm, and extracellular matrix) and aerated area (white space) within the tissue sections. Spearman's correlation coefficients were used to evaluate the extent of association between μCT imaging and histopathology endpoints. RESULTS:TNF-Tg mice had significantly greater tissue volume, total lung volume and mean intensity at all timepoints compared to age matched WT littermates. Histomorphometry also demonstrated a significant increase in tissue area at 3, 4, and 5.5 months of age in TNF-Tg mice. Lung tissue volume was correlated with lung tissue area (ρ = 0.81, p<0.0001), and normalize lung aerated volume was correlated with normalized lung air area (ρ = 0.73, p<0.0001). CONCLUSIONS:We have validated in vivo μCT as a quantitative biomarker of ILD in mice. Further, development of longitudinal measures is critical for dissecting pathologic progression of ILD, and μCT is a useful non-invasive method to study lung inflammation in the TNF-Tg mouse model.
first_indexed 2024-04-13T20:58:42Z
format Article
id doaj.art-129515b00c92492bb5ff23349742c60f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T20:58:42Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-129515b00c92492bb5ff23349742c60f2022-12-22T02:30:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01131e019067810.1371/journal.pone.0190678Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.Richard D BellChristopher RudmannRonald W WoodEdward M SchwarzHomaira RahimiINTRODUCTION:Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine models recapitulating RA-ILD are lacking, and CT outcomes for inflammatory lung disease have yet to be formally validated. To address this, we validate μCT outcomes for ILD in the tumor necrosis factor transgenic (TNF-Tg) mouse model of RA. METHODS:Cross sectional μCT was performed on cohorts of male TNF-Tg mice and their WT littermates at 3, 4, 5.5 and 12 months of age (n = 4-6). Lung μCT outcomes measures were determined by segmentation of the μCT datasets to generate Aerated and Tissue volumes. After each scan, lungs were obtained for histopathology and 3 sections stained with hematoxylin and eosin. Automated histomorphometry was performed to quantify the tissue area (nuclei, cytoplasm, and extracellular matrix) and aerated area (white space) within the tissue sections. Spearman's correlation coefficients were used to evaluate the extent of association between μCT imaging and histopathology endpoints. RESULTS:TNF-Tg mice had significantly greater tissue volume, total lung volume and mean intensity at all timepoints compared to age matched WT littermates. Histomorphometry also demonstrated a significant increase in tissue area at 3, 4, and 5.5 months of age in TNF-Tg mice. Lung tissue volume was correlated with lung tissue area (ρ = 0.81, p<0.0001), and normalize lung aerated volume was correlated with normalized lung air area (ρ = 0.73, p<0.0001). CONCLUSIONS:We have validated in vivo μCT as a quantitative biomarker of ILD in mice. Further, development of longitudinal measures is critical for dissecting pathologic progression of ILD, and μCT is a useful non-invasive method to study lung inflammation in the TNF-Tg mouse model.http://europepmc.org/articles/PMC5761871?pdf=render
spellingShingle Richard D Bell
Christopher Rudmann
Ronald W Wood
Edward M Schwarz
Homaira Rahimi
Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
PLoS ONE
title Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
title_full Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
title_fullStr Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
title_full_unstemmed Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
title_short Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
title_sort longitudinal micro ct as an outcome measure of interstitial lung disease in tnf transgenic mice
url http://europepmc.org/articles/PMC5761871?pdf=render
work_keys_str_mv AT richarddbell longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT christopherrudmann longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT ronaldwwood longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT edwardmschwarz longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT homairarahimi longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice